10-Year checkup for shoulder implant: will it last?

NCT ID NCT07663552

Disease control Sponsor: FX Solutions Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study will follow 40 people who receive a shoulder replacement using the HUMELOCK II stem, either for a broken shoulder or to replace an old implant. Researchers will track how long the implant lasts, how well the shoulder moves, and any problems over 10 years. The goal is to see if this device works well in real life over the long term.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance: HUMELOCK II long cemented humeral stem (shoulder prosthesis)
What this could lead to: If successful, this study could confirm that the HUMELOCK II stem is safe and durable for long-term use in shoulder replacement.
What could go wrong: This is an observational follow-up study with only 40 patients, so results may not apply to everyone. It does not test a new treatment, only tracks existing ones.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Jun 2037

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Study population is issued from investigators' patient population.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Indication for hemi anatomic or total reversible shoulder replacement with Long Cemented HUMELOCK II® humeral stem for Trauma or Revision indication, according to its IFU and surgical technique. * Patient aged 18 years and above * Patient insured with a social security system * Has been informed and did consent to participate to the study. Exclusion Criteria: * Neurological pathologies compromising the shoulder stability * Morbid obesity * Muscular deficiencies impairing the shoulder joint

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Humeral fracture, proximal are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

humerus fracture Shoulder Fractures

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Humeral fracture, proximal Revision of A shoulder prosthesis

How to take part

Only the study team decides who joins. These are the ways to reach them.

The places running it

4 sites. The list below names each one and where it is.
The official record

ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

Open the record ↗
A doctor treating you

A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

10-Year checkup for shoulder implant: will it last?

What the study statuses mean